Stroke and Bleeding Risks in Patients with Atrial Fibrillation Treated with Reduced Apixaban Dose: A Real‐Life Study-Reference-Cited by-同舟云学术

Stroke and Bleeding Risks in Patients with Atrial Fibrillation Treated with Reduced Apixaban Dose: A Real‐Life Study

Published:2020-08-06 Issue:6 Volume:108 Page:1265-1273
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Salameh Maram¹,Gronich Naomi²³,Stein Nili²,Kotler Antonio⁴,Rennert Gad²³,Auriel Eitan⁵⁶,Saliba Walid²³

Affiliation:

1. Pharmaceutical Services Lady Davis Carmel Medical Center Haifa Israel

2. Department of Community Medicine and Epidemiology Lady Davis Carmel Medical Center Haifa Israel

3. Ruth and Bruce Rappaport Faculty of Medicine Technion–Israel Institute of Technology Haifa Israel

4. Institute of Hematology Lady Davis Carmel Medical Center Haifa Israel

5. The Department of Neurology Rabin Medical Center Petach Tikva Israel

6. Sackler Faculty of Medicine Tel Aviv University Tel‐Aviv Israel

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1952

Reference26 articles.

1. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

2. Increased Atrial Fibrillation Mortality: United States, 1980-1998

3. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

4. Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke

5. Apixaban, a direct factor Xa inhibitor: single‐dose pharmacokinetics and pharmacodynamics of an intravenous formulation [abstract 148];Frost C.;J. Clin. Pharmacol.,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Effectiveness and Safety of Off-Label Underdosed Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis;Drug Safety;2024-08-30

2. One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke;Journal of Thrombosis and Thrombolysis;2024-03-31

3. Off-Label Reduced Dose Apixaban in Older Adults With Atrial Fibrillation and Associated Outcomes;Annals of Pharmacotherapy;2023-09-15

4. Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis;Open Heart;2023-05

5. An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation;Clinical and Applied Thrombosis/Hemostasis;2023-01